Literature DB >> 27296806

[Twenty-five years of the French Addictovigilance Network (FAN)].

Joëlle Micallef1, Michel Mallaret2.   

Abstract

Based on recommendations from the World Health Organization (WHO), the French addictovigilance network was set up since 1990, in order to assess and to monitor the potential for abuse and dependence of psychoactive substances. This network composed of 13 addictovigilance centers implemented in medical pharmacology departments of French university hospitals has developed specific pharmacoepidemiological tools repeated each year so as to lead us to updated pharmacological indicators related to drug abuse. As a single source may not be informative enough, the French addictovigilance network consider simultaneously a range of indicators focusing on health insurance database, health professional sentinel networks, characteristics of psychotropic consumptions and analysed them from a medical and pharmacological point of view combined to pharmacodynamic and pharmacokinetic data. The task force and the original role of this addictovigilance network is to work with reactivity to all different levels (local, regional, national) linked to all heath professionals in order to detect more quickly a potential warning signal leading to information, public health decision at a regional and/or national level and contributing also to a European and an international overview.
Copyright © 2016 Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Addictovigilance; Pharmacologie; Pharmacology; Population; Safety; Sécurité; Vigilance

Mesh:

Substances:

Year:  2016        PMID: 27296806     DOI: 10.1016/j.therap.2016.05.001

Source DB:  PubMed          Journal:  Therapie        ISSN: 0040-5957            Impact factor:   2.070


  3 in total

1.  Consumption of psychoactive substances in prison: Between initiation and improvement, what trajectories occur after incarceration? COSMOS study data.

Authors:  Morgane Rousselet; Marylène Guerlais; Pascal Caillet; Bertrand Le Geay; Damien Mauillon; Patrick Serre; Pierre-Yves Chameau; Yves Bleher; Serge Mounsande; Pascale Jolliet; Caroline Victorri-Vigneau
Journal:  PLoS One       Date:  2019-12-04       Impact factor: 3.240

2.  Increase of high-risk tramadol use and harmful consequences in France from 2013 to 2018: Evidence from the triangulation of addictovigilance data.

Authors:  Anne Roussin; Thomas Soeiro; Charlotte Fouque; Emilie Jouanjus; Elisabeth Frauger; Nathalie Fouilhé; Michel Mallaret; Joëlle Micallef; Maryse Lapeyre-Mestre
Journal:  Br J Clin Pharmacol       Date:  2022-04-05       Impact factor: 3.716

3.  Adverse events of recreational cannabis use during pregnancy reported to the French Addictovigilance Network between 2011 and 2020.

Authors:  Emilie Bouquet; Céline Eiden; Bernard Fauconneau; Charlotte Pion; Stéphanie Pain; Marie-Christine Pérault-Pochat
Journal:  Sci Rep       Date:  2022-10-03       Impact factor: 4.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.